Neuronal axon mimetics for in vitro analysis of neurological diseases, myelination, and drug screening
US-10845360-B2 · Nov 24, 2020 · US
US11535826B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11535826-B2 |
| Application number | US-201815975452-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 9, 2018 |
| Priority date | May 10, 2017 |
| Publication date | Dec 27, 2022 |
| Grant date | Dec 27, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Materials and methods for cell-mimetics having mechanical properties of biological neural axons are provided. A cell-mimetic device includes an array of fibers comprised of hexanediol diacrylate (HDDA) or an HDDA derivative, and at least one derivative of polyethylene glycol (PEG) selected from the group consisting of: PEG-acrylate, PEG-diacrylate, and any multi-arm PEG-acrylate.
Opening claim text (preview).
What is claimed is: 1. A cell-mimetic device comprising: an array of fibers comprised of a material comprising: hexanediol diacrylate (HDDA); and at least one of PEG-acrylate, PEG-diacrylate, and a multi-arm PEG-acrylate, wherein at least a subset of the array of fibers is free-standing pillars. 2. The cell-mimetic device of claim 1 , wherein the free-standing pillars have a pillar height of about 10 μm to about 1000 μm. 3. The cell-mimetic device of claim 1 , wherein the free-standing pillars have a pillar height of about 20 μm to about 100 μm. 4. The cell-mimetic device of claim 1 , wherein the material comprises poly(HDDA-co-starPEG). 5. The cell-mimetic device of claim 4 , wherein the poly(HDDA-co-starPEG) material comprises about 1% to about 99% w/w HDDA. 6. The cell-mimetic device of claim 5 , wherein the poly(HDDA-co-starPEG) material comprises about 5% to about 50% w/w HDDA. 7. The cell-mimetic device of claim 5 , wherein the poly(HDDA-co-starPEG) material comprises about 5% to about 35% w/w HDDA. 8. The cell-mimetic device of claim 5 , wherein the poly(HDDA-co-starPEG) material comprises about 10% to about 30% w/w HDDA. 9. The cell-mimetic device of claim 1 , wherein the fibers have a post-curing stiffness of between about 0.1 and 200 kPa. 10. The cell-mimetic device of claim 9 , wherein the fibers have a post-curing stiffness of between about 0.1 kPa and 50 kPa. 11. The cell-mimetic device of claim 9 , wherein the fibers have a post-curing stiffness of between about 0.1 kPa and 10 kPa. 12. The cell-mimetic device of claim 9 , wherein the fibers have a post-curing stiffness of between about 0.1 kPa and 1 kPa. 13. The cell-mimetic device of claim 1 , wherein the fibers have diameters between about 0.1 μm to 20 μm. 14. The cell-mimetic device of claim 13 , wherein the fibers have diameters between about 1 μm to 20 μm. 15. The cell-mimetic device of claim 1 , wherein at least a subset of the fibers are arranged in a horizontal configuration. 16. The cell-mimetic device of any of claim 15 wherein the subset of fibers in the horizontal configuration each include a suspended portion. 17. The cell-mimetic device of claim 16 wherein the subset of fibers are suspended between supports at a distance of about 0.5 μm to about 1000 μm. 18. The cell-mimetic device of claim 16 wherein the subset of fibers are suspended between supports at a distance of about 10 μm to about 200 μm. 19. The cell-mimetic device of claim 1 , wherein the fibers are modified by a surface ligand. 20. The cell-mimetic device of claim 1 , wherein the array of fibers is arranged in a three-dimensional (3D) structure comprising fibers having cylindrically exposed portions. 21. An assay method comprising: contacting the device recited in claim 1 with at least one population of cells; and studying at least one feature of an interaction of the at least one population of cells with at least one of: (a) the device, (b) a molecular compound, a drug or active pharmaceutical ingredient, and (c) another population of cells. 22. An assay method of claim 21 wherein fibers represent neuronal axons and studied interactions between cells and fibers comprise neural cell differentiation and myelination, for animal or human origin cells. 23. A method of manufacturing the cell mimetic device of claim 1 comprising a Projected Microstereolithography method. 24. A method of manufacturing the cell mimetic device of claim 1 , comprising: generating a series of digital images of a microstereolithography mask; sequentially projecting the images, illuminated by a light source, onto a resin bath comprising a material comprising hexanediol diacrylate (HDDA) and at least one of PEG-acrylate, PEG-diacrylate, and a multi-arm PEG-acrylate; and causing an exposed portion of the material to cure, the cured material forming the array of fibers of the cell-mimetic device. 25. The method of claim 24 , wherein the array includes fibers arranged in a horizontal configuration. 26. The method of claim 25 , wherein at least a subset of the fibers in the horizontal configuration each include a suspended portion. 27. The method of claim 24 , wherein the array includes fibers arranged in a vertical or tilted configuration.
Polymers of esters · CPC title
Material Coatings (immunocoatings C12M25/00) · CPC title
Processes of additive manufacturing · CPC title
Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title
the energy source being concentrated, e.g. scanning lasers or focused light sources · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.